Correlation Engine 2.0
Clear Search sequence regions


  • acetyl (1)
  • degarelix (9)
  • GnRH receptor (1)
  • humans (1)
  • oligopeptides (2)
  • product (2)
  • Sizes of these terms reflect their relevance to your search.

    Degarelix is a gonadotropin-releasing hormone (GnRH) receptor antagonist. Upon contact with physiological fluid, degarelix undergoes quick gelation and forms a depot at the site of injection providing sustained release. The molecular gelling kinetics is a critical physiochemical quality attribute of degarelix products that may impact drug delivery. However, high-resolution and drug substance (DS)-specific analytical methods for characterizing gelling kinetics of degarelix are still lacking. Accordingly, the current study focused on developing NMR-based methods to characterize in vitro initial aggregation of degarelix in Firmagon® drug product (DP). The high-precision real-time NMR method was demonstrated to quickly differentiate lot to lot differences in degarelix aggregation kinetics, and to reveal the effects of degarelix concentration, pH, salt, and temperature on the kinetics. The results could be useful for quality assurance of degarelix products and facilitate complex generic drug development. The real-time NMR method developed here could also be adopted to other complex DPs that have varied aggregation and release properties.

    Citation

    Sharadrao M Patil, Bin Qin, Yan Wang, Snober Ahmed, Huzeyfe Yilmaz, Xiaohui Jiang, David A Keire, Kang Chen. A Real-Time NMR Method for Measurement of In Vitro Aggregation Kinetics Of Degarelix Drug Products. AAPS PharmSciTech. 2021 Feb 14;22(2):73

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 33586081

    View Full Text